Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
PZ HTL SA
GLOBETECH PUBLISHING

Blocking New Blood Vessel Formation Cures Alzheimer's Disease in Mouse Model

By BiotechDaily International staff writers
Posted on 21 Mar 2013
Vaccination of mice with a syndrome that mimics human Alzheimer's disease (AD) with amyloid-beta protein normalized the production of bloods vessels in the brains of the animals and eliminated the accumulation of amyloid plaque.

Investigators at the University of British Columbia (Vancouver, Canada) worked with the Tg2576 mouse AD model. In addition to the characteristic amyloid-beta (A-beta) plaques that characterize the brain in AD, these animals displayed an abnormal number of brain blood vessels. Some of these blood vessels were incomplete and caused leakiness in the blood-brain barrier (BBB).

The investigators immunized a group of Tg2576 mice with peptides derived from the amyloid-beta protein. They reported in the February 28, 2013, online edition of the journal Scientific Reports that immunization with A-beta peptides neutralized the amyloid trigger leading to formation of new blood vessels and reversed the abnormal number of these vessels in the Tg2576 AD mice. Reduction in number of blood vessels resolved the animals' plaque burden, suggesting that formation of new blood vessels (neoangiogenesis) was a key mechanism underlying plaque formation.

“The discovery provides further evidence of the role that an overabundance of brain blood vessels plays in AD, as well as the potential efficacy of amyloid-beta as basis for an AD vaccine,” said senior author Dr.Wilfred Jefferies, professor of medical genetics at the University of British Columbia. “Now that we know blood vessel growth is a factor in AD, if follows that drugs targeting blood vessels may be good candidates as an AD treatment.”

Related Links:
University of British Columbia



Channels

Drug Discovery

view channel

Retinoic Acid Prevents Precancerous Breast Cells from Progressing to Full-Blown Cancer

Retinoic acid, a derivative of vitamin A, was found to prevent pre-cancerous breast cells from progressing to full-blown cancer but did not have any effect on breast tumor cells. Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with a novel breast cancer model that had been developed by treating... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Business

view channel

Analytical Sciences Trade Fair Declared a Rousing Success

Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event. The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.